SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Biotech / Medical: Pharm
Posts: 22 | Member SubjectMarks: 0 | No Bans

Add SubjectMark | Show Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: Jacob Snyder -- (Moderated) -- Started: 3/18/2010 12:32:52 PM  Revision History

Previous 10 | Next 10 | View Recent | Post Message Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
22[Text Chart] PFE, MRK slip down the rankings, as NVS, SNY, and GSK gain. Jacob Snyder-02/17/2011 11:25 PM
21SNY 2010 Earnings Call notes: EPS (in $/SNY): 4.61 2009 4.69 2010 4.34 2011 (miJacob Snyder-02/10/2011 09:25 PM
20Company ranked by P/e; P/cf, on 1/4/11: Sanofi Aventis (SNY) 7.5, 7.7 Merck (MRKJacob Snyder-02/05/2011 12:10 AM
19Big Pharma Dividend Stocks seekingalpha.com  (lots of graphs in original) Jacob Snyder-12/16/2010 01:03 PM
18GSK: An Atypical Dividend Investment ...historical study shows that investors cJacob Snyder-12/16/2010 12:50 PM
17How do you pick between the pharms? 1. pipeline 2. dividend yield; history ofJacob Snyder-08/12/2010 12:17 PM
16Abbott is a great value under 52 IMO Billytickets-08/12/2010 12:45 AM
15Glaxo Antibiotic Finding Looms Large in Drug Market of Few New Products years fJacob Snyder-08/06/2010 03:29 PM
14% of revenue from Emerging Markets:[Text Chart] Top 7 Emerging Markets = China, Jacob Snyder-05/23/2010 04:17 AM
13ABT: Very steady EPS increases from 2003 on: $2.05, $2.27, $2.50, $2.53, $2.84,Jacob Snyder-05/22/2010 07:55 PM
12Pharm news: The sector as a whole beat consensus estimates by 3% on sales and oJacob Snyder-05/16/2010 04:48 PM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.